GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair

Xu, H; Jin, J; Chen, Y; Wu, GQ; Zhu, H; Wang, Q; Wang, J; Li, SG; Grigore, FN; Ma, J; Chen, CC; Lan, Q; Li, M

Lan, Q (通讯作者)，Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou 215004, Jiangsu, Peoples R China.;Lan, Q (通讯作者)，Soochow Univ, Inst Neurosci, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215004, Jiangsu, Peoples R China.;Li, M (通讯作者)，Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA.

ONCOGENE, 2022; 41 (31): 3876

Abstract

Glioblastoma is the most common malignant brain cancer with dismal survival and prognosis. Temozolomide (TMZ) is a first-line chemotherapeutic agent f......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索